The metabolic syndrome: A critical appraisal based on the CUORE epidemiologic study

Preventive Medicine

Volumn 48, Issue 6, 2009, Pages 525-531

  Giampaoli, Simona ^a   Stamler, Jeremiah ^b   Donfrancesco, Chiara ^a   Panico, Salvatore ^c   Vanuzzo, Diego ^d   Cesana, Giancarlo ^e   Mancia, Giuseppe ^e   Pilotto, Lorenza ^d   Mattiello, Amalia ^c   Chiodini, Paolo ^f   Palmieri, Luigi ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Agenzia Regionale della Sanita   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiovascular risk assessment; CUORE Project; Metabolic syndrome; Prospective epidemiologic study

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; HUMAN; ITALY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL; CONFIDENCE INTERVALS; DISEASE OUTBREAKS; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 67349246801     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.03.017     Document Type: Article

References (35)

1. Ackerknecht E.H. Rudolf Virchow, Doctor, Statesman, Anthropologist (1953), University of Wisconsin Press, Madison, WI
2. Bonora E., Kiechl S., Willeit J., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck Study. Diabetes Care 26 (2003) 1251-1257
3. Campbell G. General methodology I: advances in statistical methodology for the evaluation of laboratory tests. Stat. Med. 13 (1994) 499-508
4. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
6. Farinaro E., Stamler J., Upton M., et al. Plasma glucose levels: long-term effect of diet in the Chicago Coronary Prevention Evaluation Program. Ann. Intern. Med. 86 (1977) 147-154
7. Ferrario M., Chiodini P., Chambless L.E., et al. for the CUORE Project Research Group. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int. J. Epidemiol. 34 (2005) 413-421
8. Ford E.S. Risk for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care 28 (2005) 1768-1778
9. Gami A.S., Witt B.J., Howard D.E., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49 (2007) 403-414
10. Giampaoli S., Palmieri L., Panico S., et al. Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings from 12 Italian population samples. Am. J. Epidemiol. 163 (2006) 893-902
11. Heyden S., Borhani N.O., Tyroler H.A., et al., for the Hypertension Detection and Follow-up Program Cooperative Group. The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension. J. Chronic. Dis. 38 (1985) 281-288
12. Hunt K.J., Resendez R.G., Williams K., et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004) 1251-1257
13. Jeppesen J., Hansen T.W., Rasmussen S., et al. Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population based study. Atherosclerosis 189 (2006) 369-374
14. Kahn R., Buse J., Ferrannini E., et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
15. Lawlor D.A., Davey Smith G., and Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 49 (2005) 41-48
16. Lloyd-Jones D.M., Liu K., Colangelo L.A., et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation 115 (2007) 1004-1011
17. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
18. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 28 (2005) 385-390
19. Meigs J.B., Wilson P.W.F., Nathan D.M., et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52 (2003) 2160-2167
20. MONICA Monograph and Multimedia Sourcebook. World's largest study of heart disease, stroke, risk factors, and population trends 1979-2002. In: Tunstall-Pedoe H. (Ed). Prepared by Tunstall-Pedoe H, Kuulasmaa K, Tolonen H, Davidson M, Mendis S with 64 other contributors for The WHO MONICA Project (2003), World Health Organization, Geneva
21. Noto D., Barbagallo C.M., Cefalù A.B., et al. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population. Atherosclerosis 197 (2008) 147-153
22. Onat A., Ceyhan K., Basar O., et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165 (2002) 285-292
23. Palmieri L., Donfrancesco C., Giampaoli S., et al. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur. J. Cardiovasc. Prev. Rehabil. 13 (2006) 562-570
24. Panico S., Palmieri L., Donfrancesco C., et al. Preventive potential of body mass reduction to lower cardiovascular risk: the Italian Progetto CUORE study. Prev. Med. 47 1 (2008) 53-60
25. Resnick H.E., Jones K., Ruotolo G., et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: The Strong Heart Study. Diabetes Care 26 (2003) 861-867
26. Scuteri A., Najjar S.S., Morrell C.H., et al. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: The Cardiovascular Health Study. Diabetes Care 28 (2005) 882-887
27. Stamler J. Established major coronary risk factors. In: Marmot M., and Elliott P. (Eds). Coronary Heart Disease Epidemiology: From Aetiology to Public Health (1992), Oxford University Press, New York, NY 35-66
28. Stamler J., Caggiula A.W., Cutler J.A., et al., guest scientific editors. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am. J. Clin. Nutr. 65 1 Suppl (1997) 183S-402S
29. Stamler J., Stamler R., Neaton J.D., et al. Low risk factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy. JAMA 282 (1999) 2012-2018
30. Stamler J., Neaton J., Garside D., et al. Current status: six established major risk factors - and low risk. In: Marmot M., and Elliott P. (Eds). Coronary Heart Disease Epidemiology: From Aetiology to Public Health (2005), Oxford University Press, London 32-70 Second edition
31. Stern M.P., Williams K., González-Villapando C., et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 27 (2004) 2676-2681
32. Wannamethee S.G., Shaper A.G., Lennon L., et al. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch. Intern. Med. 165 (2005) 2644-2650
33. Wilson P.W.F., Kannel W.B., Silbershatz H., et al. Clustering of metabolic factors and coronary heart disease. Arch. Intern. Med. 159 (1999) 1104-1109
34. Wilson P.W.F., D'Agostino R.B., Parise H., et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
35. Yarnell J.W.G., Patterson C.C., Bainton D., et al. Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart 79 (1998) 248-252